Depharm SRL
13.6 FTEThe score of Depharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +16 % Equity +520 % Total assets -2 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Depharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €1.24m | ||||
| Net result | 122,905 € | ||||
| Equity | €25.3m | ||||
| Cash | 116,379 € | ||||
| EBITDA | 404,399 € | ||||
| Total assets | €26.8m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 12 Jul 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
Depharm's financial analysis
- Solvency94.6%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Depharm
Depharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0445.912.760
- VAT number
- BE0445912760
- Peppol
- Registered · 0208:0445912760 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Dec 1991
- Registered office
- 1301 Wavre
- Size
- Small · 13.6 FTE
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Depharm (SRL) has been based in Wavre since 1991, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €1.24m, a net profit of 122,905 € and equity of €25.3m. With 13.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 94.6%, above the median of its sector (43.9%).
Companies similar to Depharm
Companies in the same business, of comparable size and area, outside its group.
- UPSA Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €104.2m
- Bausch & Lomb Pharma Wholesale of pharmaceutical and medical goods Wavre · balance sheet €9.17m
- Abbvie Wholesale of pharmaceutical and medical goods Wavre · balance sheet €227.4m
- Merck Wholesale of pharmaceutical and medical goods Hoeilaart · balance sheet €26.6m
- Vantive Belgium Wholesale of pharmaceutical and medical goods Braine-l'Alleud · balance sheet €23.3m
- Recordati Wholesale of pharmaceutical and medical goods Jette · balance sheet €20.8m
- DE Ceunynck Medical Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet €16.9m
- MED Concept Europe Wholesale of pharmaceutical and medical goods Woluwe-Saint-Pierre · balance sheet €18.7m
Frequently asked questions about Depharm
What is the revenue of Depharm?
According to the 2025 annual accounts filed with the NBB, the revenue of Depharm amounts to 1,244,074 €.
What is the VAT number of Depharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0445912760 for Depharm, if the company is VAT-registered. Its company number (CBE) is 0445.912.760.
Where is the registered office of Depharm?
According to the CBE register, the registered office of Depharm is in 1301 Wavre.
What is the equity of Depharm?
At the close of the 2025 financial year, the equity of Depharm amounts to 25,301,814 €, a solvency of 94.6% of total assets.
How many people work at Depharm?
13.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Depharm?
The register lists 2 active mandates at Depharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Depharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →